ÂÜÀòÂÒÂ×

Gina Ewy has extensive work experience in the field of global market access, pharmaceutical pricing, and healthcare decision analysis. Gina began their career in 1996 as a Senior Associate at Lash Group and later moved on to Covance in 1998 in the same role. In 2000, Gina became the Vice President at Cambridge Pharma Consultancy and also held the position of Vice President at IMS during the same time period. In 2002, they joined Amgen as the Director of Global Value Access and Policy, where they were responsible for strategic planning and partnership with various departments. Gina then worked as a Partner at Jupiter Life Science Consulting from 2015 to 2018. Gina also taught as an Adjunct Instructor at the University of Southern California from 2016 to 2018, specializing in healthcare decision analysis for pharmacy students. Additionally, they had a brief teaching role at UNC Kenan-Flagler Business School in 2016, where they taught a course on global healthcare management. Currently, Gina is the Vice President of Global Market Access at Hansa Biopharma AB (publ), a position they have held since 2018.

Gina Ewy has a diverse education history. Gina first attended Denison University from 1980 to 1984, where they obtained a Bachelor's Degree in Biology, with a focus on General Biology. After completing their undergraduate studies, they attended Capital University Law School from 1990 to 1992, where they earned a Doctor of Law (JD) degree. Following their interest in the medical field, Gina pursued further education at The Ohio State University from 1993 to 1995. There, they obtained a Master's in Medical Clinical Sciences/Graduate Medical Studies with a specialization in the same field. Additionally, Gina Ewy also holds a certification in Health Outcomes and PharmacoEconomics Training, although the specific institution and year of completion are not provided.